532067 — 3B Blackbio DX Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹8.84bn
- IN₹8.25bn
- IN₹741.25m
- 93
- 15
- 65
- 62
Annual cashflow statement for 3B Blackbio DX, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 100 | 1,520 | 432 | 353 | 443 |
| Depreciation | |||||
| Non-Cash Items | 3.39 | 2.28 | 1.06 | 1.98 | -56.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -38.8 | -554 | -66.8 | -135 | -128 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 70.4 | 975 | 373 | 229 | 270 |
| Capital Expenditures | -5.35 | -16.8 | -22.6 | -20.2 | -5.08 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.04 | -686 | -262 | 141 | -198 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.4 | -703 | -284 | 121 | -203 |
| Financing Cash Flow Items | -3.34 | -0.492 | 12.7 | -0.675 | -1.25 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.1 | -15.7 | -151 | -50.1 | -36.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 72.1 | 257 | -61.9 | 303 | 29.4 |